RSV vaccine protects older adults against severe illness
A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. “This Kaiser Permanente research demonstrated the real-world effectiveness of RSV vaccination among ...
Featured News
Study finds air pollution may increase risk of preterm birth
Exposure to a specific kind of air pollution, fine particulate matter, during pregnancy may significantly increase the risk of spontaneous preterm birth, which can be dangerous for both the mother and ...
5 questions for … Dr. Javed Sheikh
Javed Sheikh, MD, was recently named 2024 Physician Researcher of the Year by the Southern California Permanente Medical Group. Dr. Sheikh is the vice area research chair for the Los Angeles area on ...
Kaiser Permanente’s vaccine side-effect monitor bolsters safety
After COVID-19 vaccines became available in December 2020, several smartphone-based reporting systems were developed to monitor vaccine side effects. They included V-safe from the Centers for Disease ...
Increased health care use among patients after COVID-19
August 12, 2022A study led by Kaiser Permanente in Southern California of patients from 8 health care organizations across the United States showed that COVID-19 was associated with a 4% increase in use of health care services over the 6 months after initial infection. The study was published August 12, 2022, in JAMA Network Open. Some people who were ...Read more...Child abuse–related emergency department visits increased after pandemic lock-down
August 8, 2022The rate of emergency department visits associated with child abuse or neglect at Kaiser Permanente Southern California hospitals doubled immediately after the March 2020 stay-at-home order. This increase in the rate of child maltreatment visits was highest among younger children, girls, and children who were Black or Hispanic. Over the following year and a half, ...Read more...COVID-19 boosters shown to be effective for adolescents
August 3, 2022Adolescents who received 3 doses of the Pfizer–BioNTech COVID vaccine were better protected against infection with SARS-CoV-2 — the virus that causes COVID-19 — than adolescents who received only 2 doses, according to a study of more than 3,000 Kaiser Permanente Southern California members ages 12 to 17 and published on August 3, 2022, in ...Read more...5 questions for … Dr. Jennifer Ku
July 28, 2022An infectious disease epidemiologist, Jennifer Ku, PhD, MPH, is in the first year of her postdoctoral program at the Department of Research & Evaluation. Her research includes vaccine safety and effectiveness projects on shingles and COVID-19 vaccines. Dr. Ku is also involved in other infectious diseases studies on influenza, SARS-CoV-2, and other respiratory viruses. Please tell ...Read more...Public policy can improve pandemic masking adherence
July 25, 2022A year-long study of mask adherence and social distancing among more than 100,000 people in 126 U.S. cities found people were 3 times more likely to wear masks correctly in places where a mask mandate was in place. The study was published recently in the American Journal of Infection Control. “City, county, and state leaders can ...Read more...5 questions for … Dr. Rulin Hechter
June 30, 2022Rulin Hechter, MD, PhD, is an infectious disease epidemiologist in the Department of Research & Evaluation who focuses on the prevention and treatment of HIV and other sexually transmitted infections. She received her medical training from Suzhou Medical College and her master’s degree in epidemiology and biostatistics from Fudan University, both in China. She received ...Read more...Down syndrome linked to higher risk of severe COVID-19
June 28, 2022Before COVID-19 vaccines became available, people with Down syndrome were less likely to be diagnosed with COVID-19 than people without the condition, according to a study of more than 12,000 Kaiser Permanente Southern California members published on June 24, 2022, in The Journal of Infectious Diseases. However, the study found that people with Down syndrome faced ...Read more...Dr. Anny Xiang honored with prestigious American Diabetes Association award
June 27, 2022Anny Xiang, PhD, MS, scientific director of the Division of Biostatics Research at the Department of Research & Evaluation, received the American Diabetes Association’s 2022 Norbert Freinkel Award on June 4, 2022. The lecture award is the ADA’s highest award for outstanding contributions in the field of diabetes and pregnancy. “Dr. Xiang’s body of work has ...Read more...COVID-related hospitalizations are rare after Paxlovid treatment
June 21, 2022In December 2021, the Pfizer-BioNTech medication Paxlovid received emergency authorization as a treatment to prevent severe health problems from COVID-19 that could lead to hospitalization and death. But recently, small studies with less than a dozen people began to show up in the media linking the medication to a rebound in COVID-19 symptoms following recovery. On ...Read more...Omicron variant infections less severe than delta
June 13, 2022A study of patients at Kaiser Permanente in Southern California showed that when both the delta and omicron variants were circulating in December 2021, patients who had SARS-CoV-2 infections with the omicron variant had substantially less risk of severe illness and shorter hospital stays than those infected with the delta variant. The study was published ...Read more...